Black Elderberry Extract
INCI: Black Elderberry Extract (Sambucus nigra extract)
Black elderberry extract is a botanical ingredient derived from the berries of Sambucus nigra, traditionally used in food supplements. It is one of the most familiar and commercially understood gummy actives across EU and US markets. No EFSA-authorised health claims exist under Reg. (EU) 432/2012; claim coverage, if desired, must come from co-formulated nutrients.
- immune support
- antioxidant
- daily wellness
At a glance
- Definition
- Black elderberry extract is a botanical ingredient derived from the berries of Sambucus nigra, traditionally used in food supplements. It is one of the most familiar and commercially understood gummy actives across EU and US markets. No EFSA-authorised health claims exist under Reg. (EU) 432/2012; claim coverage, if desired, must come from co-formulated nutrients.
- Common positionings
- immune support
- antioxidant protection
- daily wellness
- seasonal wellness
- respiratory comfort
- Format suitability
- Reviewed for gummies and sachets — confirmed per project.
Where this ingredient fits in the DAT Supply catalogue
Every format chip links through to its manufacturing hub and to the private-label catalogue for that format. The category chip routes to the matching vertical hub on the categories index.
- Botanicals & mushrooms
- Browse all ingredients
What it is
Black elderberry extract is a botanical ingredient derived from the berries of the Sambucus nigra plant, native to Europe and parts of Asia and North America. It has a long history of use in traditional food supplements and is now one of the most widely recognised botanical ingredients in the gummy category across EU and US markets.
Brands choose black elderberry extract for its strong consumer recognition, pleasant berry flavour profile, and compatibility with gummy manufacturing. Its low cost tier and good heat stability make it a practical choice for private-label gummy ranges targeting daily wellness and immune support positioning.
Origin and history
Sambucus nigra, commonly known as black elder or European elder, has been used in traditional European herbalism for centuries. The berries and flowers have been consumed in syrups, cordials, and food preparations across many cultures. Commercial cultivation of elderberries for supplement production is concentrated in Europe, particularly in Austria, Germany, and Eastern European countries.
Industrial production of black elderberry extract involves harvesting ripe berries, drying, and extracting with water or ethanol to concentrate the bioactive compounds. The extract is then standardised to a specific ratio (commonly 5:1 or 10:1) and spray-dried or concentrated into a powder suitable for gummy and sachet manufacturing.
Scientific overview
Black elderberry berries contain a range of bioactive compounds including anthocyanins, flavonoids (particularly quercetin and rutin), phenolic acids, and vitamins. The anthocyanin content gives the berries their characteristic deep purple colour and contributes to their antioxidant properties. These compounds are known to interact with cellular signalling pathways involved in oxidative stress responses.
The bioavailability of elderberry anthocyanins is relatively low after oral consumption, with most absorption occurring in the small intestine and colon. Standardised extracts aim to provide consistent levels of these compounds per serving. The choice of extraction solvent (water vs. ethanol) affects the profile of extracted compounds, with ethanol generally yielding higher anthocyanin content.
From a manufacturing perspective, black elderberry extract is heat-stable and soluble in gummy formulations, making it straightforward to incorporate. The pleasant berry flavour profile can complement or reduce the need for additional flavouring. Cost per mg is low, making it an economical choice for gummy ranges targeting broad consumer appeal.
Why brands use Black Elderberry Extract
Black elderberry extract is one of the most familiar and commercially understood gummy actives across EU and US markets. Consumer awareness of elderberry is high, particularly in the context of seasonal wellness and immune support. This recognition translates into strong retail performance and consumer trust, making it a staple ingredient for brands launching gummy ranges in the daily wellness and immune support categories.
From a formulation and manufacturing perspective, black elderberry extract offers several advantages. It is heat-stable, soluble in gummy matrices, and has a pleasant berry flavour that can reduce the need for artificial flavouring. The low cost tier makes it accessible for brands targeting competitive price points. Standard processing applies with no special formulation requirements, simplifying scale-up and production.
For pack copy, brands must exercise claim discipline. Black elderberry is a botanical on the EU on-hold list with no authorised health claims under Reg. (EU) 432/2012. Any claim positioning must be reviewed per project. If brands wish to make structure-function claims, these must be supported by co-formulated nutrients with authorised claims (e.g., Vitamin C for immune function). DAT confirms compliance per project after reviewing target market, claim strategy, and regulatory documentation. No disease claims, no "anti-inflammatory" in EU pack copy, no certification promises on pack until confirmed per project and batch, and no guaranteed shelf-life on pack until confirmed with stability data.
Formats this ingredient is reviewed for
DAT Supply covers gummy, capsule, softgel, tablet, powder, oral strip, liquid drop, shot, jelly and pet formats. The list below reflects every format this ingredient is reviewed for — chips link through to the manufacturing hub for each format. Final compatibility, dose and matrix are confirmed per project.
Formulation notes
Verified formulation reference across the formats this ingredient is reviewed for — the Supported formats section lists every product format this active is approved for, and the per-format Considerations section below covers matrix-specific guidance. Final formulation, dose and on-pack copy are confirmed per project.
- Gummy fit
- Good
- Heat stable
- Yes
- Soluble in matrix
- Yes
- Cost tier
- Low
Forms available
- Standardised extract (typically 5:1 or 10:1), juice concentrate powder, spray-dried powder
Dosage reference
No EFSA-authorised claim exists for black elderberry. Brand positioning typically ranges from 50–500 mg per serving. DAT confirms dosage per project after reviewing target market, claim strategy, and stability data.
Taste & sensory
Pleasant berry flavour. Easy to incorporate.
Manufacturing notes
No specific formulation notes. Standard processing applies.
Per-format formulation notes
Safe-baseline considerations for each format this ingredient is reviewed for. Final formulation, dose and on-pack copy are confirmed per project.
Gummies
- Taste masking and aroma load against the cooked-base flavour — confirmed per project.
- Heat exposure during cooking; coated or encapsulated forms may be required — confirmed per project.
- Matrix choice (pectin vs gelatin) and its effect on ingredient stability — confirmed per project.
- Per-gummy dose and serving count needed to hit the label claim — confirmed per project.
Sachets
- Powder flow and dose accuracy at single-serve sachet weights — confirmed per project.
- Barrier requirements (oxygen, moisture) for the active — confirmed per project.
- Reconstitution behaviour when the sachet is dosed into water — confirmed per project.
EU-authorised health claims
EU-authorised wording for this ingredient is reviewed per project against Reg. 1924/2006 and the authorised list under Reg. 432/2012. No final claim wording is implied by this page.
Authorised at ≥15% NRV per daily serving. Claim wording must appear verbatim on consumer packaging. DAT reviews final pack copy per project against EU 1924/2006 and the authorised list under EU 432/2012.
Black elderberry is a botanical on the EU on-hold list. No authorised health claims under Reg. (EU) 432/2012. Any claim positioning must be reviewed per project. DAT confirms compliance per project after reviewing target market, claim strategy, and regulatory documentation.
Studies & evidence
External peer-reviewed sources and regulatory opinions. Citations only — DAT does not endorse the publishers.
- [01] Elderberry (Sambucus nigra L.) — A systematic review of its bioactive compounds and health effects
Vlachojannis, J.E., Cameron, M., Chrubasik, S.·Phytotherapy Research·2010
Tiralongo, E., Wee, S.S., Lea, R.A.·Nutrients·2016
Tiralongo, E., Wee, S.S., Lea, R.A.·Nutrients·2016
- [04] Anthocyanins from black elderberry (Sambucus nigra L.) — A review of their chemistry and bioactivity
Kaack, K., Aust, L.·European Food Research and Technology·1998
EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)·EFSA Journal·2011
Synergies & conflicts
Pairs well with
Synergy data needs review.
Care when combining with
Conflict data needs review.
Similar ingredients
Ingredients that frequently sit alongside this one in private-label supplement briefs.

Aloe Vera
Aloe Vera (Aloe barbadensis) is a succulent plant whose inner gel is used in food supplements for its hydrating and soothing properties. As a botanical on the EU on-hold list, it carries no authorised health claims under Reg. 432/2012. Brands typically position it around general wellness, digestive comfort, and skin hydration, often co-formulated with Vitamin C or probiotics for claim support.

Artichoke
Artichoke (Cynara scolymus) is a botanical ingredient used in dietary supplements for its traditional association with digestive and liver function. It is one of the most familiar and commercially understood botanical actives across EU and US markets. As a botanical on the EU on-hold list, no authorised health claims are currently permitted under Reg. 432/2012.

Arugula Extract
Arugula extract is a botanical ingredient derived from Eruca sativa leaves, used in gummy and sachet formats for green superfood and daily wellness positioning. It is a botanical on the EFSA on-hold list with no authorised health claims under Reg. (EU) 432/2012. Any claim coverage must come from co-formulated nutrients.

Ashwagandha
Ashwagandha (Withania somnifera) is a traditional Ayurvedic root used historically for stress, vitality, and sleep. In gummy formats it is most commonly positioned within stress-and-calm or sleep stacks. Ashwagandha sits on the EFSA "on-hold" list of botanical claims, with no authorised EU health claims of its own; substantiated claim wording in Ashwagandha gummies typically derives from co- formulated nutrients such as Magnesium and Vitamin B6.

Bacopa Extract
Bacopa Extract (Bacopa monnieri) is a botanical ingredient traditionally used in Ayurvedic wellness systems. In private-label gummy manufacturing, it is positioned for cognitive support, memory, and stress resilience. Bacopa has no EFSA-authorised health claims under Reg. 432/2012; claim coverage for cognitive function relies on co-formulated nutrients such as Vitamin B6, B12, or Iron.

Bamboo Extract
Bamboo extract is a plant-derived ingredient standardised for silica content, sourced from Bambusa vulgaris. It is used in gummy and sachet formulations as a natural source of silicon, a mineral involved in connective tissue structure. Under EU Regulation 432/2012, bamboo extract carries no authorised health claims; brands typically co-formulate with Biotin, Zinc, or Vitamin C for hair, skin, and nails positioning.
Adjacent reading
Pairings, resource guides and blog notes most often associated with Black Elderberry Extract on DAT Supply briefs.
Develop a formula featuring Black Elderberry Extract
Explore concepts already built around this ingredient, or talk to our team to scope a custom formulation.